Managing bowel obstruction in ovarian cancer using a percutaneous endoscopic gastrostomy (PEG) tube

Can Oncol Nurs J. 2003 Fall;13(4):212-9. doi: 10.5737/1181912x134212215.
[Article in English, French]


An estimated 2,500 women were diagnosed with and 1,500 died from ovarian cancer in Canada in 2002. Up to 42% of patients in the palliative phase develop a malignant bowel obstruction. Options for management include medical therapy, surgery, and/or a percutaneous endoscopic gastrostomy (PEG) tube. The objective of this quality improvement study was to: 1) examine if successful palliation was achieved using a PEG tube, and 2) identify opportunities to improve the quality of nursing care provided. A retrospective review of 24 patient records revealed that 75% did not have nausea/vomiting by time of discharge; 92% resumed a clear fluid diet; 83% were discharged from the acute care setting; and 70% did not require re-admission. A PEG tube may effectively palliate women with non-operable bowel obstruction in advanced/recurrent cancer of the ovary. Opportunities for improving care are presented.

MeSH terms

  • Female
  • Gastroscopy / methods*
  • Gastroscopy / nursing
  • Gastroscopy / standards
  • Gastrostomy / methods*
  • Gastrostomy / nursing
  • Gastrostomy / standards
  • Humans
  • Intestinal Obstruction / etiology*
  • Intestinal Obstruction / therapy*
  • Nurse's Role
  • Nursing Audit
  • Nursing Evaluation Research
  • Oncology Nursing / methods
  • Oncology Nursing / standards
  • Ovarian Neoplasms / complications*
  • Palliative Care / methods*
  • Palliative Care / standards
  • Patient Readmission
  • Retrospective Studies
  • Total Quality Management / organization & administration
  • Treatment Outcome